| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 04/21/1998 | US5741894 Heating crosslinked and uncrosslinked hemoglobin in presence of nonstoichiometric amounts of oxygen resulting in precipitation of uncrosslinked hemoglobin |
| 04/21/1998 | US5741891 Pulmonary surfactant peptide solubilization process |
| 04/21/1998 | US5741781 Mercaptoalkanoyldipeptide compounds |
| 04/21/1998 | US5741713 Contacting with a target receptor molecule so that a selected labeled biochemical compound binds to the receptor |
| 04/21/1998 | US5741686 Exopeptidase catalyzed site-specific bonding of supports, labels and bioactive agents to proteins |
| 04/21/1998 | US5741669 Insecticidally effective peptides |
| 04/21/1998 | US5741642 Assay for detecting the expression of a gene encoding human keratinocyte growth factor (KGF) |
| 04/21/1998 | US5741485 Crystalline complexes has monoclinic morphology and x-ray diffraction |
| 04/21/1998 | US5741462 Remotely programmable matrices with memories |
| 04/16/1998 | WO1998015825A2 Matrices with memories in automated drug discovery and units therefor |
| 04/16/1998 | WO1998015658A1 Compositions and methods for treating viral infections |
| 04/16/1998 | WO1998015620A1 Polymer-protein composites and methods for their preparation and use |
| 04/16/1998 | WO1998015574A1 Methods and compositions for generating angiostatin |
| 04/16/1998 | WO1998015571A1 Modified cytostatic agents |
| 04/16/1998 | WO1998011229A3 Histidine-tagged shiga toxins, toxoids, and protein fusions with such toxins and toxoids, methods for the purification and preparation thereof |
| 04/16/1998 | DE19640970A1 Modifizierte Cytostatika Modified cytostatics |
| 04/16/1998 | CA2268261A1 Polymer-protein composites and methods for their preparation and use |
| 04/16/1998 | CA2267769A1 Matrices with memories in automated drug discovery and units therefor |
| 04/16/1998 | CA2265550A1 Methods and compositions for generating angiostatin |
| 04/15/1998 | EP0835939A2 Fusion proteins with parts of immunoglobulins, their production and use |
| 04/15/1998 | EP0835323A1 Modified proteins and methods of their production |
| 04/15/1998 | EP0801655B1 Basic proline-amide derivatives of ge 2270 and ge 2270-like antibiotics |
| 04/15/1998 | CN1178798A Method for removing N-terminal methionine |
| 04/15/1998 | CN1038035C Preparing method for polyethylene protein conjugates |
| 04/15/1998 | CN1038034C Rapid synthesis and screening of peptide mimetics |
| 04/15/1998 | CA2218456A1 Purified stat proteins and methods of purifying thereof |
| 04/14/1998 | US5740072 Method of using a computer processor |
| 04/14/1998 | US5739386 Photolabile compounds and methods for their use |
| 04/14/1998 | US5739350 CC-1065 analogs |
| 04/14/1998 | US5739293 Contacting impure protein fraction with cation-exchange medium to bind impurities but not glycoprotein, binding glycoprotein to anion-exchange mediu, eluting |
| 04/14/1998 | US5739288 Fibrin sealant compositions |
| 04/14/1998 | US5739281 Subjecting proteins to a time sequence of multiple denaturing-renaturing cycles |
| 04/14/1998 | US5739274 Comprising polypeptide linked to phospholipid; produces delayed increase in blood pressure, increase in extracellular calcium uptake by vascular smooth muscle |
| 04/14/1998 | US5739272 Procedure for obtaining carbocalcitonin |
| 04/14/1998 | US5739157 Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase |
| 04/14/1998 | US5739116 Enediyne derivatives useful for the synthesis of conjugates of methyltrithio antitumor agents |
| 04/14/1998 | US5738996 Used in selecting an oligomer compound capable of interacting specifically with a selected macromolecular receptor |
| 04/14/1998 | US5738878 Purification, isolation by eluting with aqueous methanol solution; liquid chromatography |
| 04/14/1998 | US5738848 Immunosuppressive compounds and method of preparing same |
| 04/14/1998 | US5738846 Conjugating interferon to polymer strand having one or both ends activated by carbamate-or amide-forming groups |
| 04/14/1998 | US5738784 Device for separating a blood component from blood or plasma |
| 04/14/1998 | CA2116691C Plasma fraction purification |
| 04/09/1998 | WO1998014770A1 High throughput solid phase chemical synthesis utilizing thin cylindrical reaction vessels useable for biological assay |
| 04/09/1998 | WO1998014589A1 Thermostable dna polymerase from carboxydothermus hydrogenoformans |
| 04/09/1998 | WO1998014479A1 Method of searching for physiologically active substances and process for producing the same |
| 04/09/1998 | WO1998014473A1 Colostrinin, and uses thereof |
| 04/09/1998 | WO1998014467A1 Method of purifying protein from inclusion bodies |
| 04/09/1998 | WO1998014463A1 MAGE-10 ENCODING cDNA, THE TUMOR REJECTION ANTIGEN PRECURSOR MAGE-10, ANTIBODIES SPECIFIC TO THE MOLECULE, AND USES THEREOF |
| 04/09/1998 | WO1998014271A1 Replaceable elements for a parallel sequential bio-polymer synthesis device |
| 04/09/1998 | CA2279232A1 Replaceable elements for a parallel sequential bio-polymer synthesis device |
| 04/09/1998 | CA2267641A1 Method of purifying protein from inclusion bodies |
| 04/09/1998 | CA2267202A1 Mage-10 encoding cdna, the tumor rejection antigen precursor mage-10, antibodies specific to the molecule, and uses thereof |
| 04/08/1998 | EP0834576A2 Methods using nucleic acid hybridization patterns on a matrix of oligonucleotides |
| 04/08/1998 | EP0834575A2 Methods using target nucleic acid hybridization patterns on a matrix of oligonucleotides |
| 04/08/1998 | EP0834569A1 Thermostable DNA polymerase from carboxydothermus hydrogenoformans |
| 04/08/1998 | EP0834562A1 Polypetide exhibiting calpain inhibition activity and method for the preparation thereof |
| 04/08/1998 | EP0833919A1 Type f botulinum toxin and use thereof |
| 04/08/1998 | EP0833847A1 Crystals of fragments of cd40 ligand and their use |
| 04/08/1998 | EP0833838A1 Methods for reducing background binding in antibody preparations |
| 04/08/1998 | EP0833837A1 Process for preparing derivatives of azabicyclo naphthyridine carboxylic acid comprising a dipeptide |
| 04/08/1998 | EP0833836A1 Conformationally-restricted combinatorial library composition and method |
| 04/08/1998 | EP0833835A1 Obesity protein intermediates and their preparation and use |
| 04/08/1998 | EP0833659A1 Therapeutic fragments of von willebrand factor |
| 04/08/1998 | EP0439508B1 Polyethylene glycolcol (peg)-protein adducts and process for their fractionation |
| 04/07/1998 | US5736521 Administering amino acid compound |
| 04/07/1998 | US5736519 Enhances reconstitution of cells of hematopoietic and immune systems following radiation or chemotherapy induced suppression |
| 04/07/1998 | US5736394 Cellular uptake of modified peptides |
| 04/07/1998 | US5736340 Secreted Mac-2-binding glycoprotein |
| 04/07/1998 | US5736339 Method utilizing purified GP IIb-IIIa to detect the presence of platelet aggregation inhibitors |
| 04/07/1998 | US5736138 Antagonist |
| 04/07/1998 | CA1339808C Glycopeptide antibiotics |
| 04/02/1998 | WO1998013781A1 System and method for structure-based drug design that includes accurate prediction of binding free energy |
| 04/02/1998 | WO1998013496A1 Chaperone fragments |
| 04/02/1998 | WO1998013007A2 Methods and compositions for lipidization of hydrophilic molecules |
| 04/02/1998 | CA2267179A1 Methods and compositions for lipidization of hydrophilic molecules |
| 04/01/1998 | EP0832900A1 Peptide and method of obtaining it |
| 04/01/1998 | EP0832268A1 A method of expressing and secreting soluble extracellular domains of humain gonadotropin hormone receptors |
| 04/01/1998 | EP0832228A1 Modified hemoglobin-like compounds and methods of purifying same |
| 04/01/1998 | EP0832223A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY AND METHODS FOR PREPARATION |
| 04/01/1998 | EP0832220A1 Ob protein compositions and method |
| 04/01/1998 | EP0832131A1 Separating unmodified hemoglobin from cross-linked hemoglobin |
| 04/01/1998 | EP0832130A1 Separation of hemoglobin on hydroxyapatite using hplc |
| 04/01/1998 | EP0832121A1 Methods for purifying authentic igf from yeast hosts |
| 04/01/1998 | EP0832108A1 Process for recovering water-insoluble compounds from a fermentation broth |
| 04/01/1998 | EP0832104A1 Novel dolastatin derivatives, their preparation and use |
| 04/01/1998 | EP0832098A1 Method of producing igf-i and igfbp-3 with correct folding and disulfide bonding |
| 04/01/1998 | EP0832097A1 A system and method for the modification and purification of peptides |
| 04/01/1998 | EP0832096A1 Synthesis of proteins by native chemical ligation |
| 04/01/1998 | EP0831936A1 Thiolation of peptides for radionuclide-based radiodetection and radiotherapy |
| 04/01/1998 | EP0831790A2 Methods for stably incorporating substances within dry, foamed glass matrices and compositions obtained thereby |
| 04/01/1998 | CN1177982A System for the expression of heterologous antigens as fusion proteins |
| 03/31/1998 | US5734026 Process for manufacturing crystals of growth hormone and crystals thereby obtained |
| 03/31/1998 | US5734018 Biosynthesis detection, analyzing method to obtain peptide sequences |
| 03/31/1998 | US5734011 Ligand precursors for incorporation into peptides |
| 03/31/1998 | US5733984 Process for the preparation of a deuterated compound |
| 03/31/1998 | US5733928 15-deoxyspergualin analogs, their method of preparation and their use in therapeutics |
| 03/31/1998 | US5733546 Immunochemical detection of in vivo advanced glycosylation endproducts |
| 03/31/1998 | CA1339793C Cyclic analogs of atrial natriuretic peptides |
| 03/31/1998 | CA1339791C Human nerve growth factor |
| 03/26/1998 | WO1998012563A1 Method to detect dirofilaria immitis infection |